Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
Diabetologia
|
July 1, 1985
Hyperinsulinaemia and insulin insensitivity: studies in subjects with insulinoma
A Nankervis, J Proietto, P Aitken, et al.
Diabetologia
|
September 1, 1983
Insulin resistance in alloxan-diabetic dogs: evidence for reversal following insulin therapy
G Caruso, J Proietto, A Calenti, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
January 1, 1979
Insulin and glucagon responses of transplanted intrasplenic pancreatic islets
B N Gray, G Caruso, F Alford, et al.
Diabetologia
|
October 1, 1983
Glucose utilization in Type 1 (insulin-dependent) diabetes: Evidence for a defect not reversible by acute elevations of insulin
J Proietto, A Nankervis, P Aitken, et al.
British Medical Journal
|
October 14, 1972
Periodicity of serum prolactin concentration
Y Patel, G Baker, F Alford, et al.
Diabetologia
|
February 1, 1994
Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment
H Beck-Nielsen, O Hother-Nielsen, A Vaag, et al.
Diabetologia
|
October 1, 1982
Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes
A Nankervis, J Proietto, P Aitken, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
February 1, 1994
A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain
M F Alford, E Masliah, L A Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 20, 1998
Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy
M Christopher, F L Hew, M Oakley, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
September 30, 1999
The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy
D N O'Neal, F L Hew, J D Best, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
Diabetologia
|
July 1, 1985
Hyperinsulinaemia and insulin insensitivity: studies in subjects with insulinoma
A Nankervis, J Proietto, P Aitken, et al.
Diabetologia
|
September 1, 1983
Insulin resistance in alloxan-diabetic dogs: evidence for reversal following insulin therapy
G Caruso, J Proietto, A Calenti, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
January 1, 1979
Insulin and glucagon responses of transplanted intrasplenic pancreatic islets
B N Gray, G Caruso, F Alford, et al.
Diabetologia
|
October 1, 1983
Glucose utilization in Type 1 (insulin-dependent) diabetes: Evidence for a defect not reversible by acute elevations of insulin
J Proietto, A Nankervis, P Aitken, et al.
British Medical Journal
|
October 14, 1972
Periodicity of serum prolactin concentration
Y Patel, G Baker, F Alford, et al.
Diabetologia
|
February 1, 1994
Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment
H Beck-Nielsen, O Hother-Nielsen, A Vaag, et al.
Diabetologia
|
October 1, 1982
Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes
A Nankervis, J Proietto, P Aitken, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
February 1, 1994
A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain
M F Alford, E Masliah, L A Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 20, 1998
Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy
M Christopher, F L Hew, M Oakley, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
September 30, 1999
The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy
D N O'Neal, F L Hew, J D Best, et al.
Page
of 6